At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 14 enrolled
Drug / intervention
Sitagliptin +1 moredrug
Likely dose
Sitagliptin 100mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Sitagliptin on Postprandial Glycaemia, Incretin Hormones and Blood Pressure in Type 2 Diabetes - Relationship to Gastric Emptying
In Brief
A Phase 2 clinical trial evaluating Sitagliptin and Placebo for Gastroparesis and Diabetes Mellitus. Completed, enrolled 14 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the acute effects of sitagliptin on postprandial glycemia, incretin hormones and blood pressure, and the relationship to gastric emptying, after a mashed potato meal in patients with type 2 diabetes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastroparesis, Diabetes Mellitus
CountriesAustralia
Collaborators--
Timeline
Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 2014
Enrollment StartJul 2015
Primary CompletionJan 2017
TodayJul 2026
First PostedDec 24, 2014
Enrollment StartJul 1, 2015
Primary CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 11.5 years ago
Interventions
Sitagliptindrug
100mg mane for 2 days
Placebodrug
Inactive drug (Placebo)